Guangdong Lifestrong Pharmacy Co., Ltd.

301111

CNE1000054T7

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-22 pm EDT			5-day change	1st Jan Change
15.95 ^CNY	-3.33%		-4.89%	-35.06%

Apr. 26	Guangdong Lifestrong Pharmacy Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 21	Guangdong Lifestrong Pharmacy Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Guangdong Lifestrong Pharmacy Co., Ltd. Approves Cash Dividend for 2021

May 17, 2022 at 03:37 pm EDT

Guangdong Lifestrong Pharmacy Co., Ltd. at its AGM held on 16 May 2022 approved cash dividend of CNY 1.60000000 per 10 shares for 2021.

Latest news about Guangdong Lifestrong Pharmacy Co., Ltd.

Guangdong Lifestrong Pharmacy Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 26	CI
Guangdong Lifestrong Pharmacy Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 21	CI
Guangdong Lifestrong Pharmacy Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Guangdong Lifestrong Pharmacy Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-25	CI
Guangdong Lifestrong Pharmacy Approves Final Cash Dividend on A Shares for 2022, Effective 01 June 2023	23-05-22	CI
Guangdong Lifestrong Pharmacy Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Certain A Shares of Guangdong Lifestrong Pharmacy Co., Ltd. are subject to a Lock-Up Agreement Ending on 8-DEC-2022.	22-12-07	CI
Certain A Shares of Guangdong Lifestrong Pharmacy Co., Ltd. are subject to a Lock-Up Agreement Ending on 3-DEC-2022.	22-12-02	CI
Guangdong Lifestrong Pharmacy Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-26	CI
Guangdong Lifestrong Pharmacy Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-29	CI
Guangdong Lifestrong Pharmacy to Free Up Nearly 2 Million Shares For Trading	22-06-06	MT
Guangdong Lifestrong Pharmacy Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2021, Payable on May 26, 2022	22-05-20	CI
Guangdong Lifestrong Pharmacy Co., Ltd. Approves Cash Dividend for 2021	22-05-17	CI
Guangdong Lifestrong Pharmacy Co., Ltd. Proposes Cash Dividend for 2021	22-04-25	CI
Guangdong Lifestrong Pharmacy Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-25	CI
Guangdong Lifestrong Pharmacy Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-24	CI
Guangdong Lifestrong Pharmacy Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-11-16	CI
Guangdong Lifestrong Pharmacy Co., Ltd. has withdrawn its IPO.	21-04-28	CI
Guangdong Lifestrong Pharmacy Co., Ltd. has filed an IPO.	20-12-22	CI

Chart Guangdong Lifestrong Pharmacy Co., Ltd.

Duration

Period

Chart Guangdong Lifestrong Pharmacy Co., Ltd.

More charts

Guangdong Lifestrong Pharmacy Co Ltd is a China-based company mainly engaged in the research and development (R&D), production and sales of Chinese patent medicines. The Company is also engaged in the production and sales of masks. The Company's main products include XiaoyanLidan Tablets, Danshitong Capsules, CanqiJiangtang Tablets, Kumu Injection, Fuyanping Capsules, Guipi Liquid, Gujing Bushen Pills, Jianer Qingjie Liquid and other medicines. The Company's products application scope covers biliary tract, hypoglycemic, heat clearing and detoxification, gynecology, tonic, pediatrics, cough and asthma, cardio cerebrovascular, cold, urology, digestion, rheumatism and traumatology.

Sector

Pharmaceuticals

Calendar

2024-08-26 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
GUANGDONG LIFESTRONG PHARMACY CO., LTD.	-35.06%	365M
ELI LILLY AND COMPANY	+38.69%	723B
NOVO NORDISK A/S	+34.28%	595B
JOHNSON & JOHNSON	-4.49%	369B
MERCK & CO., INC.	+20.24%	332B
ABBVIE INC.	+2.12%	282B
ASTRAZENECA PLC	+17.02%	244B
NOVARTIS AG	+9.31%	208B
ROCHE HOLDING AG	-5.07%	205B
PFIZER, INC.	-0.35%	168B